VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
BKYI
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
BKYIBIO-key International, Inc.
$4.60$3M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
  1. Home
  2. Financial Ratios

  1. Home
  2. Stocks
  3. BKYI
  4. Financial Ratios

BIO-key International, Inc. (BKYI) Financial Ratios

Latest Ratios: P/E Ratio -0.7x · EV/EBITDA N/A · ROE -80.2%. (1996–2025 historical series)

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly

BKYI Valuation Multiples

Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Market Cap$3M$4M$4M$2M$5M$17M$27M$7M$9M$12M$15M
Enterprise Value$412190$937441$5M$2M$5M$10M$11M$10M$8M$11M$14M
P/E Ratio →-0.67——————————
P/S Ratio0.500.590.510.220.663.379.643.142.151.864.98
P/B Ratio0.400.470.931.580.871.101.35—0.830.850.96
P/FCF———————————
P/OCF———————————

P/E links to full P/E history page with 30-year chart

BKYI EV Ratios

Enterprise-value multiples — capital-structure-neutral measures of total business value

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
EV / Revenue—0.150.700.200.741.903.914.342.071.824.62
EV / EBITDA———————————
EV / EBIT———————————
EV / FCF———————————

BKYI Profitability

Margins and return-on-capital ratios measuring operating efficiency

Margins

Full margin charts and quarterly trend are on the Earnings History page

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Gross Margin77.5%77.5%81.4%18.5%65.2%67.3%72.0%-8.5%-3.0%-2.9%75.5%
Operating Margin-69.9%-69.9%-57.9%-113.8%-141.4%-96.6%-183.4%-596.2%-169.8%-67.8%-141.2%
Net Profit Margin-75.3%-75.3%-62.1%-109.9%-169.7%-99.0%-341.0%-643.4%-169.8%-67.8%-140.8%

Return on Capital

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
ROE-80.2%-80.2%-177.9%-267.8%-113.9%-28.2%-107.2%-356.6%-56.7%-29.3%-24.9%
ROA-47.1%-47.1%-65.5%-107.5%-81.8%-25.1%-77.3%-205.6%-49.5%-25.6%-22.2%
ROIC-63.1%-63.1%-99.8%-194.0%-106.1%-60.8%-172.5%-191.4%-43.6%-23.0%-22.3%
ROCE-72.0%-72.0%-149.5%-245.4%-91.6%-27.1%-55.5%-315.5%-56.7%-29.3%-25.0%

BKYI Leverage & Debt

Solvency and debt-coverage ratios — lower is generally safer

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Debt / Equity0.010.010.470.340.610.020.04————
Debt / EBITDA———————————
Net Debt / Equity—-0.340.36-0.140.11-0.48-0.80—-0.03-0.02-0.07
Net Debt / EBITDA———————————
Debt / FCF———————————
Interest Coverage-13.40-13.40-13.42-38.66-1139.35-280.43-1.23-12.65———

Net cash position: cash ($3M) exceeds total debt ($48994)

BKYI Liquidity & Efficiency

Short-term solvency ratios and asset-utilisation metrics

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Current Ratio1.491.490.410.821.657.0110.100.313.453.022.67
Quick Ratio1.371.370.330.680.834.549.920.212.632.612.42
Cash Ratio0.870.870.100.160.483.889.330.130.260.120.58
Asset Turnover—0.560.801.720.620.290.130.910.350.390.17
Inventory Turnover3.703.703.4114.190.550.342.405.744.176.851.57
Days Sales Outstanding—74.4841.7461.2381.7578.65116.2538.14147.16172.91198.32

BKYI Shareholder Yields

Earnings, FCF, buyback, and dividend yields — total returns to shareholders

Dividends

Full dividend history and growth charts are on the Dividend History page

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Dividend Yield—————————5.4%3.6%
Payout Ratio———————————

Total Shareholder Return Metrics

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Earnings Yield———————————
FCF Yield———————————
Buyback Yield0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Total Shareholder Yield0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%5.4%3.6%
Shares Outstanding—$664770$205988$56028$43682$43288$43181$9878$8061$4610$3880

Key Metrics

Growth RegimeContracting
ProfitabilityNegative
Balance SheetVulnerable
Cash FlowBurning
Top Statement Risk

Liquidity and dilution risk

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Distressed Valuation Reflects Operational Uncertainty

Based on reported figures, BKYI trades at a P/S multiple of 0.50, which, when viewed alongside a negative TTM P/E of -0.67, suggests that the market is pricing the company as a distressed asset rather than a growth-oriented software provider within the identity management sector.

The current valuation multiples appear to reflect deep skepticism regarding the company's ability to achieve a sustainable path to profitability. Investors should monitor whether this discount is a temporary market mispricing or a structural reflection of the company's inability to scale its PortalGuard platform effectively against larger, more established competitors.

Persistent Decay in Invested Capital

According to recent financial statements, BKYI's ROIC has remained consistently negative, reaching -1.7% in 2026Q1, which indicates that the company is failing to generate adequate returns on its capital base and is instead eroding shareholder value through ongoing operational losses.

The inability to achieve positive returns on invested capital suggests that the company's core business model lacks the necessary efficiency to justify its current capital structure. This trend warrants further investigation into whether the company's R&D and marketing expenditures are yielding any tangible competitive advantage or if they are merely sustaining a non-viable cost base.

Working Capital Volatility Hinders Efficiency

As reported in financial statements, BKYI's cash conversion cycle has shown extreme volatility, swinging from 225 days in 2023Q4 to -21 days in 2025Q2, which highlights significant challenges in managing receivables and inventory within its lumpy, project-based revenue model.

The erratic nature of the cash conversion cycle suggests that the company lacks control over its working capital, likely due to the unpredictable timing of large international civil identification contracts. This operational inconsistency complicates cash flow forecasting and increases the risk of liquidity shortfalls during periods of delayed customer payments.

Liquidity Buffer Remains Precariously Thin

Based on recent SEC filings, BKYI's current ratio of 1.41 in 2026Q1 provides only a narrow margin of safety, which appears insufficient given the company's history of burning cash and its reliance on external financing to fund ongoing operations.

The company's liquidity position appears vulnerable to even minor operational disruptions or delays in project-based revenue recognition. Investors should monitor the company's cash burn rate closely, as the current liquidity profile may necessitate further dilutive capital raises to maintain basic corporate functions.

Misapplication of Revenue-Based Valuation Metrics

As evidenced by the company's financial history, the P/S ratio is frequently misapplied to BKYI, as it obscures the underlying quality of revenue and the high cost of customer acquisition required to sustain the company's transition toward a recurring software-as-a-service model.

Relying on P/S multiples ignores the fact that a significant portion of BKYI's revenue may be tied to low-margin, one-time hardware sales or lumpy project-based contracts. A more appropriate metric for this business model would be an adjusted ARR-to-EV multiple, which would better capture the value of the recurring software component while stripping out the volatility of the legacy hardware business.

Download Financial Ratios Data

Includes 30+ ratios · 30 years · Updated daily

Consensus-Based Analysis Tools

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

BKYI — Frequently Asked Questions

Quick answers to the most common questions about buying BKYI stock.

What is BIO-key International, Inc.'s P/E ratio?

BIO-key International, Inc.'s current P/E ratio is -0.7x. The historical average is 2.0x.

What is BIO-key International, Inc.'s ROE?

BIO-key International, Inc.'s return on equity (ROE) is -80.2%. The historical average is -115.7%.

Is BKYI stock overvalued?

Based on historical data, BIO-key International, Inc. is trading at a P/E of -0.7x. Compare with industry peers and growth rates for a complete picture.

What are BIO-key International, Inc.'s profit margins?

BIO-key International, Inc. has 77.5% gross margin and -69.9% operating margin.